Navigation Links
Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
Date:3/4/2013

Toronto, Canada (PRWEB) March 04, 2013

With the advent of direct acting antiviral agents for the Hepatitis C virus (HCV), there has been a concerted effort to offer broad testing services and capabilities to assist clients at every stage of drug development. From lead compound optimization and resistance profiling to Phase IV marketing studies, LabCorp and its specialty testing laboratories offer specialized, proprietary testing. In fact, LabCorp offers global central laboratory testing services to support HCV trials around the world.

In this webinar, a thorough overview of currently available HCV capabilities will be presented, including:

  •     Technical overview of HCV assay services, including resistance testing (mutation detection and replicon-based DAA susceptibility assays), viral load assays, genotype/subtype characterization and IL28B allele testing
  •     Appropriate timing and circumstances for each specific test
  •     How these assays can be used to support regulatory filings
  •     How LabCorp’s global reach can help clients conduct more cost-effective clinical trials

The presentation will also highlight ongoing and future HCV assay development activities, such as the implementation of next generation sequencing platforms and the expanded presence in China, Southeast Asia and Europe.

For more information about this event or to register, visit: http://xtks.in/xto575-event

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/3/prweb10472827.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CNIO researchers take part in the most comprehensive personalized medicine study performed to date
2. Comprehensive Resource for Food Safety Diagnostics – Romer Labs Launches New Website
3. Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
4. ESTEVE Announces the Publication of Comprehensive Phase I Data for a Novel Oral, First-in-class New Chemical Entity (NCE),E-52862, a Sigma-1 Receptor Antagonist (S1RA) Being Developed for Pain
5. CIVCO to Present Comprehensive Motion Management Solutions at ASTRO 2012 Booth #10003
6. Dr. Ross Kaplan Offers New Comprehensive Acne Package Treatment for Acne and Acne Scarring
7. Taylor-Wharton CryoScience 'Partners For Life' Awards Liquid Nitrogen Freezer to Comprehensive Cancer Center at University of Alabama at Birmingham
8. Rigaku introduces the world’s most comprehensive biological SAXS system for the home lab
9. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
10. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
11. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2019)... ... , ... DermBiont, a clinical stage microbiome biotechnology company developing ... safety endpoints, with no application site reactions and no adverse events, in a ... tinea pedis (athlete’s foot). Additionally, the trial demonstrated a clinical response with improvement ...
(Date:10/10/2019)... ... 09, 2019 , ... The International Society for Pharmaceutical ... a newly-confirmed keynote speaker for the 2019 ISPE Annual Meeting & Expo ... Abernethy, a hematologist/oncologist and palliative medicine physician, is an internationally recognized clinical data ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... Project (TMP), Madhumita Suresh and Leslie Maurer presented company executives with a set ... and Science (MBS) graduates will offer insights from their TMP to a wider ...
(Date:10/3/2019)... ... October 01, 2019 , ... Cheyenne is a beautiful ... Mimi, Cheyenne’s owner, owns and operates Rebel’s Run , which offers riding lessons ... amongst students and trail riding guests. Mimi describes her as her “go to ...
Breaking Biology Technology:
(Date:10/30/2019)... (PRWEB) , ... October 30, ... ... poly(N-substituted glycine) “peptoids” exhibit self-assembly properties and bioactivity that are encoded by ... Peptoids differ from peptides in the shift of the sidechain attachment to ...
(Date:10/27/2019)... ... ... Since 2010, The HOTH has served over 200,000 businesses with awesome white-label ... they’ve earned a place on the highly-competitive and desirable Inc. 5,000 List of Fastest-Growing ... accolades along the way. , Now, The HOTH is ready to pass ...
(Date:10/26/2019)... ... 2019 , ... Nanovis today announced that it received the ... for nanotechnology. , “We are delighted to receive such an important designation ... achieving Nanovis’ goal to reduce the pain and suffering from implant loosening. With ...
Breaking Biology News(10 mins):